Guided Therapeutics (GTHP) Inventory (2011 - 2026)

Guided Therapeutics has disclosed Inventory across 16 years of filings, most recently posting $500000.0 for Q2 2026.

• In Q2 2026, Inventory fell 15.97% year-over-year to $500000.0; the TTM figure through Jun 2026 stood at $500000.0 (down 15.97% YoY), while the FY2025 annual figure was $448000.0, down 29.23% from the prior year.
• Inventory came in at $500000.0 for Q2 2026 at Guided Therapeutics, up from $469000.0 in the prior quarter.
• In the past five years, Inventory ranged from a high of $648000.0 in Q3 2023 to a low of $448000.0 in Q4 2025.
• Average Inventory over 5 years is $582333.3, with a median of $590000.0 recorded in 2023.
• Year-over-year, Inventory gained 15.33% in 2023 and dropped 29.23% in 2025.
• Over 5 years, Inventory stood at $548000.0 in 2022, then advanced by 15.33% to $632000.0 in 2023, then increased by 0.16% to $633000.0 in 2024, then retreated by 29.23% to $448000.0 in 2025, then climbed by 11.61% to $500000.0 in 2026.
• Per Business Quant data, the three most recent Inventory figures were $500000.0 in Q2 2026, $469000.0 in Q1 2026, and $448000.0 in Q4 2025.